Table II. The daily intensity of pain (VAS) of each one of the participants when
treated by Tetracycline for RAS
|
Patient # |
Days of treatment |
||||||||||
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
||
|
1 |
9 |
9 |
8 |
7 |
6 |
6 |
5 |
4 |
2 |
1 |
1 |
|
2 |
4 |
4 |
4 |
2 |
2 |
1 |
1 |
0 |
0 |
0 |
0 |
|
3 |
3 |
3 |
2 |
3 |
4 |
5 |
6 |
6 |
4 |
2 |
1 |
|
4 |
9 |
10 |
10 |
9 |
7 |
9 |
10 |
9 |
9 |
8 |
7 |
|
5 |
3 |
3 |
4 |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
|
6 |
1 |
1 |
2 |
3 |
3 |
3 |
2 |
2 |
1 |
0 |
0 |
|
7 |
8 |
8 |
7 |
7 |
7 |
6 |
6 |
5 |
4 |
3 |
2 |
|
8 |
4 |
3 |
3 |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
|
9 |
7 |
7 |
8 |
10 |
10 |
10 |
9 |
7 |
6 |
7 |
8 |
|
10 |
5 |
5 |
3 |
3 |
3 |
2 |
1 |
0 |
0 |
0 |
0 |
|
11 |
4 |
3 |
3 |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
|
12 |
10 |
9 |
7 |
5 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
|
13 |
5 |
5 |
4 |
3 |
2 |
2 |
1 |
0 |
0 |
0 |
0 |
|
14 |
7 |
7 |
5 |
3 |
2 |
1 |
1 |
0 |
0 |
0 |
0 |
|
15 |
5 |
5 |
5 |
5 |
6 |
6 |
5 |
4 |
4 |
4 |
3 |
|
16 |
8 |
5 |
5 |
5 |
6 |
6 |
5 |
4 |
4 |
4 |
3 |
|
17 |
7 |
5 |
4 |
3 |
2 |
1 |
1 |
0 |
0 |
0 |
0 |